Penserra Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,188	Closed	-$6K	–	1160
2024 Q4	$6K	Buy	1,188 +320	+37%	+$1.62K	﹤0.01%	1045
2024 Q3	$7K	Buy	+868	New	+$7K	﹤0.01%	917